AliMohamed(Hassan)SherifMD

Pediatric Nephrology • Hobbs, NM

Pediatric Hypertension Nephrology

Physician

Join to view full profile

Dr. Sherif is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sherif's full profile

Already have an account?

Office
5419 N Lovington Hwy Ste 2
Hobbs, NM 88240
Phone+1 575-392-1503
Is this information wrong?

Education & Training

Children's National Medical Center/George Washington UniversityFellowship, Pediatric Nephrology, 2009 - 2010
Driscoll Children's Hospital/Texas A&M College of MedicineResidency, Pediatrics, 2006 - 2009
Mansoura University Faculty of MedicineClass of 1997

Certifications & Licensure

TX State Medical License 2015 - 2025
NM State Medical License 2010 - 2025
VA State Medical License 2009 - 2024
DC State Medical License 2009 - 2010
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

1 citations
Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solution.
Keitaro Yokoyama, Nanae Matsuo, Hiraku Yoshida, Ali M. Sherif, Tastuhiro Yaginuma, Hiroyasu Yamamoto, Makio Kawakami, Tatsuo Hosoya> ;Kidney International. 2008 Sep 2
30 citations
Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis.
Ali M. Sherif, Hiraku Yoshida, Yukio Maruyama, Hiroyasu Yamamoto, Keitaro Yokoyama, Tatsuo Hosoya, Makio Kawakami, Masaaki Nakayama> ;Therapeutic Apheresis and Dialysis. 2008 Feb 1
28 citations
Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients
Ali M. Sherif, Masaaki Nakayama, Yukio Maruyama, Hiraku Yoshida, Hiroyasu Yamamoto, Keitaro Yokoyama, Makio Kawakami> ;Nephrology, Dialysis, Transplantation. 2006 Jun 1
4 citations
Potential applications of RNA interference-based therapeutics in the treatment of cardiovascular disease.
Ali Hassan> ;Recent Patents on Cardiovascular Drug Discovery. 2006 May 31
4 citations
Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guidelines.
Keitaro Yokoyama, Makiko Nishioka, Toru Sakuma, Satoru Yoshida, Rinako Iida, Hiraku Yoshida, Shino Hara, Ichiro Ohkido, Naohiko Katoh, Hiroyasu Yamamoto, Takashi Shige...> ;Therapeutic Apheresis and Dialysis. 2006 Feb 1
19 citations
Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis
Yasushi Otsuka, Masaaki Nakayama, Masato Ikeda, Ali M. Sherif, Keitaro Yokoyama, Hiroyasu Yamamoto, Yoshindo Kawaguchi> ;Clinical and Experimental Nephrology. 2005 Dec 1
3 citations
Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients.
Ali M. Sherif, Ayman F. Refaie, Hussein Sheashaa, Abd-Elhalim El-Tantawy, Mohamed A. Sobh> ;American Journal of Nephrology. 2004 Nov 1
45 citations
Long-term outcome of live donor kidney transplantation for renal amyloidosis
Ali M. Sherif, Ayman F. Refaie, Mohamed A. Sobh, Nagi Abdel-Hadi Mohamed, Hussein Sheashaa, Mohamed A. Ghoneim> ;American Journal of Kidney Diseases. 2003 Aug 1
Join now to see all

Hospital Affiliations

Covenant Hobbs HospitalHobbs, New Mexico